Management and Surgical Options
At a Glance
Most conjunctival nevi are benign and can be monitored with regular eye exams and photographs. Removal is considered when the spot changes, causes ongoing irritation, cannot be confidently diagnosed, or creates significant cosmetic distress; an ophthalmologist should guide the decision.
Most people with a conjunctival nevus will never need surgery. Because these “eye freckles” are overwhelmingly benign and have an extremely low risk of turning into cancer, the gold standard of care is watchful waiting [1]. This approach avoids the potential risks of surgery—such as scarring, infection, or a permanently red eye—while ensuring that any rare changes are caught early through professional monitoring [2].
The Standard: Watchful Waiting
If your eye specialist determines your nevus is clinically typical, they will likely recommend observation rather than removal [1]. This process involves:
- Regular Exams: Slit-lamp examinations to check the thickness and edges of the spot [1].
- Comparison Photos: Using high-resolution baseline photography to objectively track any changes in size, shape, or color over time [1].
- Individualized Timing: There is no one-size-fits-all schedule; your doctor will set a follow-up interval based on your age and the lesion’s appearance [1].
When Surgery is Necessary
While observation is the primary path, your doctor may recommend an excisional biopsy (complete surgical removal) in specific situations [3]:
- Suspicious Changes: The spot is growing, darkening, or developing new, prominent blood vessels [4][5].
- Diagnostic Uncertainty: The lesion has features that make it difficult to distinguish from more serious conditions like PAM or melanoma [6].
- Physical Irritation: The nevus is raised and causes a persistent “gritty” feeling or chronic redness [7].
- Cosmetic Concerns: The spot is highly visible or causes you significant emotional distress. While a valid reason to discuss removal, this is considered elective and is not medically necessary to prevent cancer in a stable nevus [1][8].
The “No-Touch” Surgical Technique
If surgery is required, specialized ocular surgeons use what is known as the no-touch technique [9]. The goal is to remove the lesion completely without ever directly grasping or traumatizing the pigment cells. This principle is intended to minimize the risk of “seeding” or spreading of cells into the surrounding healthy tissue, though it does not guarantee zero spread [10][11].
In cases where a doctor is specifically concerned about malignancy, they may also use adjunctive cryotherapy [11]. This involves “freezing” the edges of the surgical site with a specialized probe to destroy any microscopic cells that might remain at the margins [12]. Cryotherapy is not routine for a stable benign nevus and carries its own risks, including surface scarring or inflammation.
What Surgery is Like
If you proceed with excision, the procedure is typically performed under local anesthesia in an operating room or specialized clinic. Afterward, you can expect some postoperative redness, a foreign-body sensation (like sand in the eye), and the need for prescribed eye drops for several weeks. Healing takes time, and there are possible risks, including dry eye, scarring, persistent redness, and rare effects on the cornea or limbus.
Reconstructing the Eye Surface
For very small nevi, the surgeon can often pull the healthy edges of the conjunctiva back together (primary closure). However, for larger spots, specialized reconstruction is needed to ensure the eye heals smoothly and comfortably:
- Conjunctival Autograft: A small piece of healthy tissue is moved from a hidden area (usually under the upper eyelid) to cover the site where the nevus was removed [13].
- Amniotic Membrane: A specialized, thin biological “bandage” can be used to cover large gaps. It acts as a scaffold that encourages your own cells to grow over the area, often resulting in excellent cosmetic healing [8][10].
The Role of Medical Eye Drops
You may hear about using drops (like tacrolimus or anti-allergy medications) for certain eye spots. This is rare, specialist-directed, and typically reserved for a specific, niche subtype called an inflamed juvenile nevus [14]. In these cases, a true nevus has an associated inflammation or allergic reaction that makes it appear larger and redder than it actually is [14][15].
While these drops can reduce redness and shrink the inflammatory component, they are not a treatment for the nevus itself [14]. Most importantly, prescribed medical treatment should never be used as a substitute for a biopsy if a lesion looks suspicious for cancer [3]. Your doctor’s first priority is always to ensure the spot is benign before treating the inflammation around it.
Common questions in this guide
Does every conjunctival nevus need surgery?
What changes in a conjunctival nevus should prompt a biopsy?
What happens during conjunctival nevus removal?
What is recovery like after conjunctival nevus surgery?
Can eye drops make a conjunctival nevus go away?
How is a stable conjunctival nevus monitored?
When might cryotherapy be used with conjunctival nevus surgery?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Get notified when new evidence is published on conjunctival nevus.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Is my nevus stable enough for 'watchful waiting,' and what interval do you recommend for follow-up photos?
- 2.If we decide on surgery, will you use the 'no-touch' technique and adjunctive cryotherapy?
- 3.For a lesion of this size, would you recommend primary closure or a reconstruction like an amniotic membrane?
- 4.If this is an inflamed juvenile nevus, could topical drops be an option to reduce the redness before we decide on surgery?
- 5.What specific changes in size or color would make you move from observation to an immediate biopsy?
References
References (15)
- 1
Conjunctival Nevus.
Huang JJ, Locatelli EVT, Chocron A, et al.
Current ophthalmology reports 2023; (11(4)):104-112 doi:10.1007/s40135-023-00315-w.
PMID: 38390435 - 2
Regressing Conjunctival Nevus in a Child.
Ho VW, Brunner M, Hussain RN, Heimann H
Journal of ophthalmic & vision research 2018; (13(4)):501-503 doi:10.4103/jovr.jovr_215_17.
PMID: 30479722 - 3
[Evaluation of the accuracy of clinical diagnosis of conjunctival neoplasms : Comparison with histological findings after excision].
Gruben AR, Hösel K, Roider J, Ehlken C
Die Ophthalmologie 2024; (121(5)):391-396 doi:10.1007/s00347-024-02009-5.
PMID: 38446196 - 4
Conversion of Conjunctival Nevus to Melanoma in a Patient Taking the TYK2 Inhibitor Deucravacitinib.
Whitcomb N, Lee HJ
Cornea 2026; (45(1)):105-107 doi:10.1097/ICO.0000000000003942.
PMID: 40742181 - 5
Indocyanine Green Angiographic Assessment of Conjunctival Melanocytic Disorders.
Palme C, Wanner A, Romano V, et al.
Cornea 2021; (40(12)):1519-1524 doi:10.1097/ICO.0000000000002681.
PMID: 33591034 - 6
Inflammatory juvenile compound nevi: A melanoma is not all that it appears to be.
García de Oteyza G, Betancourt J, Benedetti Sandner M, et al.
Archivos de la Sociedad Espanola de Oftalmologia 2019; (94(2)):90-94 doi:10.1016/j.oftal.2018.06.022.
PMID: 30098823 - 7
Infected Inclusion Cyst of a Conjunctival Nevus Treated with a Mini-Incision: A Case Report.
Blavakis E, Kecik M, Thumann G, Massa H
Case reports in ophthalmology 2024; (15(1)):585-589 doi:10.1159/000539846.
PMID: 39144646 - 8
Surgical management of a conjunctival nevus with amniotic membrane transplantation.
Röck T, Bösmüller HC, Bartz-Schmidt KU, Röck D
International medical case reports journal 2018; (11()):161-165 doi:10.2147/IMCRJ.S164099.
PMID: 30100765 - 9
Clinical and immunohistopathological study of conjunctival melanocytic lesions in pediatric and adolescent patients. A case series.
Bogdănici CM, Costea CF, Dumitrescu GF, et al.
Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie 2021; (62(4)):907-915 doi:10.47162/RJME.62.4.03.
PMID: 35673810 - 10
Surgical amniotic membrane transplantation after conjunctival and limbal tumor excision.
Goktas SE, Katircioglu Y, Celik T, Ornek F
Arquivos brasileiros de oftalmologia 2017; (80(4)):242-246 doi:10.5935/0004-2749.20170059.
PMID: 28954025 - 11
Malignant melanoma presenting as amelanotic caruncular lesion in a child.
Walters AR, Keck KM, Simmons O, et al.
Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 2017; (21(6)):501-503 doi:10.1016/j.jaapos.2017.06.025.
PMID: 29126970 - 12
Conjunctival Melanoma in Asian Indians: A Study of 42 Patients.
Kaliki S, Vasanthapuram VH, Mishra DK
Seminars in ophthalmology 2019; (34(3)):182-187 doi:10.1080/08820538.2019.1620793.
PMID: 31135259 - 13
Conjunctival Autografts for Ocular Surface Reconstruction after Conjunctival Nevus Excision.
Ucar F
Cornea 2023; (42(10)):1206-1210 doi:10.1097/ICO.0000000000003117.
PMID: 36731062 - 14
Clinical and pathologic characteristics of inflamed juvenile conjunctival nevus and its treatment with immunosuppressant eye drops.
Tomoda A, Araki-Sasaki K, Obata H, et al.
Japanese journal of ophthalmology 2025; (69(1)):17-23 doi:10.1007/s10384-024-01140-9.
PMID: 39549215 - 15
Management of Inflamed Conjunctival Nevus with Topical Antiallergic Medications: Case Series.
Kato K, Takeuchi M, Yonekawa Y, et al.
Clinical ophthalmology (Auckland, N.Z.) 2021; (15()):559-564 doi:10.2147/OPTH.S299288.
PMID: 33603334
This page is for informational purposes only and does not constitute medical advice. An ophthalmologist or ocular surgeon should assess your conjunctival nevus and recommend the safest plan for you.